Compare Cigna Corp (CI) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Regeneron Pharmaceuticals Inc — how do they compare? Cigna Corp trades at $302.59 (market cap $80.55B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Cigna Corp is the larger of the two by market cap, and Cigna Corp pays the higher dividend (2.05%). Which is the better fit depends on your goals.
| CI | REGN | |
|---|---|---|
Market Cap | $80.55B | $69.52B |
Sector | Health | Health |
52-Week High | $311.00 | $812.27 |
52-Week Low | $244.41 | $542.52 |
Enterprise Value | $103.65B | $63.47B |
Dividend Yield | 2.05% | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
